Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 282 in Healthy Subjects and Subjects With Chronic Rhinosinusitis With Nasal Polyps [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, tolerability, pharmacokinetics, and pharmacodynamics of AMG 282 in healthy subjects and patients with chronic rhinosinusitis wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinosinusitis with Nasal Polyps

Drugs mentioned

• AMG 282

Snippet

Sponsor: Amgen | Conditions: Chronic Rhinosinusitis With Nasal Polyps | Phase 1 | Status: COMPLETED